On the public citation graph

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

0 signed · 698 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cmdc.201300525openalex-snapshot
Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex
inferredcites →https://doi.org/10.1002/eji.201444849openalex-snapshot
Gal‐3 regulates the capacity of dendritic cells to promote NKT‐cell‐induced liver injury
inferredcites →https://doi.org/10.1002/hep.20170openalex-snapshot
Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
inferredcites →https://doi.org/10.1002/hep.21223openalex-snapshot
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.21763openalex-snapshot
A lipidomic analysis of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.22519openalex-snapshot
Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
inferredcites →https://doi.org/10.1002/hep.22907openalex-snapshot
A novel pregnane X receptor and S14‐mediated lipogenic pathway in human hepatocyte†
inferredcites →https://doi.org/10.1002/hep.22950openalex-snapshot
Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis #
inferredcites →https://doi.org/10.1002/hep.23463openalex-snapshot
5-Lipoxygenase Deficiency Reduces Hepatic Inflammation and Tumor Necrosis Factor α–Induced Hepatocyte Damage in Hyperlipidemia-Prone Apoe-Null Mice
inferredcites →https://doi.org/10.1002/hep.23599openalex-snapshot
Accumulation of Natural Killer T Cells in Progressive Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1002/hep.23649openalex-snapshot
Activation of Rac1 Promotes Hedgehog-Mediated Acquisition of the Myofibroblastic Phenotype in Rat and Human Hepatic Stellate Cells
inferredcites →https://doi.org/10.1002/hep.23894openalex-snapshot
The Fractalkine Receptor CX3CR1 Protects Against Liver Fibrosis by Controlling Differentiation and Survival of Infiltrating Hepatic Monocytes
inferredcites →https://doi.org/10.1002/hep.24747openalex-snapshot
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of GS-9450 in Subjects With Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/hep.25537openalex-snapshot
S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver
inferredcites →https://doi.org/10.1002/hep.25762openalex-snapshot
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
inferredcites →https://doi.org/10.1002/hep.26081openalex-snapshot
Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice
inferredcites →https://doi.org/10.1002/hep.26271openalex-snapshot
Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents
inferredcites →https://doi.org/10.1002/hep.26351openalex-snapshot
C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice
inferredcites →https://doi.org/10.1002/hep.26461openalex-snapshot
Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/hep.26592openalex-snapshot
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
inferredcites →https://doi.org/10.1002/hep.26604openalex-snapshot
Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice
inferredcites →https://doi.org/10.1002/hep.26606openalex-snapshot
Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides
inferredcites →https://doi.org/10.1002/hep.26672openalex-snapshot
Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
inferredcites →https://doi.org/10.1002/hep.26697openalex-snapshot
Chemokine Receptor CCR6-Dependent Accumulation of γδ T Cells in Injured Liver Restricts Hepatic Inflammation and Fibrosis
inferredcites →https://doi.org/10.1002/hep.26783openalex-snapshot
Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice
inferredcites →https://doi.org/10.1002/hep.26898openalex-snapshot
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.27141openalex-snapshot
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
inferredcites →https://doi.org/10.1002/hep.27235openalex-snapshot
Treatment response in the PIVENS trial is associated with decreased hedgehog pathway activity
inferredcites →https://doi.org/10.1002/hep.27284openalex-snapshot
Fructose leads to hepatic steatosis in zebrafish that is reversed by mechanistic target of rapamycin (mTOR) inhibition
inferredcites →https://doi.org/10.1002/hep.27297openalex-snapshot
The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice
inferredcites →https://doi.org/10.1002/hep.27420openalex-snapshot
ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis
inferredcites →https://doi.org/10.1002/hep.27720openalex-snapshot
Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014
inferredcites →https://doi.org/10.1002/hep.27772openalex-snapshot
Obeticholic acid and resveratrol in nonalcoholic fatty liver disease: All that is gold does not glitter, not all those who wander are lost
inferredcites →https://doi.org/10.1002/hep.27804openalex-snapshot
Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice
inferredcites →https://doi.org/10.1002/hep.27858openalex-snapshot
A new mechanism of lipotoxicity: Calcium channel blockers as a treatment for nonalcoholic steatohepatitis?
inferredcites →https://doi.org/10.1002/path.2536openalex-snapshot
Advanced lipoxidation end‐products mediate lipid‐induced glomerular injury: role of receptor‐mediated mechanisms
inferredcites →https://doi.org/10.1007/978-3-7091-1368-4_9openalex-snapshot
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs)
inferredcites →https://doi.org/10.1007/s00109-014-1170-1openalex-snapshot
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
inferredcites →https://doi.org/10.1007/s00125-010-2001-8openalex-snapshot
Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice
inferredcites →https://doi.org/10.1007/s00125-011-2446-4openalex-snapshot
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
inferredcites →https://doi.org/10.1007/s00125-014-3350-5openalex-snapshot
Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice
inferredcites →https://doi.org/10.1007/s00204-014-1348-xopenalex-snapshot
Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms
inferredcites →https://doi.org/10.1007/s10495-015-1108-2openalex-snapshot
Autophagy in the light of sphingolipid metabolism
inferredcites →https://doi.org/10.1007/s11095-013-1101-9openalex-snapshot
Identification of Three Novel Natural Product Compounds that Activate PXR and CAR and Inhibit Inflammation
inferredcites →https://doi.org/10.1007/s11095-013-1239-5openalex-snapshot
Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
inferredcites →https://doi.org/10.1007/s12020-014-0503-8openalex-snapshot
Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice
inferredcites →https://doi.org/10.1016/j.bbadis.2014.07.002openalex-snapshot
AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response
inferredcites →https://doi.org/10.1016/j.bbadis.2015.01.014openalex-snapshot
The pharmacology of resveratrol in animals and humans
inferredcites →https://doi.org/10.1016/j.bbagen.2014.07.012openalex-snapshot
Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin
inferredcites →https://doi.org/10.1016/j.bbalip.2014.04.007openalex-snapshot
Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.bbalip.2014.08.012openalex-snapshot
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
inferredcites →https://doi.org/10.1016/j.bbamcr.2014.01.023openalex-snapshot
The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling
inferredcites →https://doi.org/10.1016/j.bbrc.2004.09.110openalex-snapshot
PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
inferredcites →https://doi.org/10.1016/j.bbrc.2006.09.069openalex-snapshot
PPARγ agonists prevent TGFβ1/Smad3-signaling in human hepatic stellate cells
inferredcites →https://doi.org/10.1016/j.bbrc.2011.02.048openalex-snapshot
Acetylation of pregnane X receptor protein determines selective function independent of ligand activation
inferredcites →https://doi.org/10.1016/j.bbrc.2011.07.038openalex-snapshot
Role of S6K1 in regulation of SREBP1c expression in the liver
inferredcites →https://doi.org/10.1016/j.bbrc.2015.02.011openalex-snapshot
Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1β, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death
inferredcites →https://doi.org/10.1016/j.biocel.2015.01.011openalex-snapshot
Activation of mTORC1 disrupted LDL receptor pathway: A potential new mechanism for the progression of non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.bioorg.2014.07.003openalex-snapshot
Human lysyl oxidase-like 2
inferredcites →https://doi.org/10.1016/j.canlet.2015.01.040openalex-snapshot
Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin
inferredcites →https://doi.org/10.1016/j.cell.2007.01.049openalex-snapshot
Complex N-Glycan Number and Degree of Branching Cooperate to Regulate Cell Proliferation and Differentiation
inferredcites →https://doi.org/10.1016/j.cell.2011.06.034openalex-snapshot
mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
inferredcites →https://doi.org/10.1016/j.cellsig.2013.09.018openalex-snapshot
Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells
inferredcites →https://doi.org/10.1016/j.cgh.2014.02.024openalex-snapshot
Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.clinbiochem.2015.06.023openalex-snapshot
Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.cmet.2011.02.004openalex-snapshot
Regulation of Lipid Homeostasis by the Bifunctional SREBF2-miR33a Locus
inferredcites →https://doi.org/10.1016/j.cmet.2011.10.002openalex-snapshot
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
inferredcites →https://doi.org/10.1016/j.cmet.2012.04.004openalex-snapshot
Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.cmet.2013.08.005openalex-snapshot
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
inferredcites →https://doi.org/10.1016/j.cmet.2014.05.001openalex-snapshot
Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
inferredcites →https://doi.org/10.1016/j.cytogfr.2014.11.009openalex-snapshot
CXCR3 ligands in disease and therapy
inferredcites →https://doi.org/10.1016/j.dld.2014.11.015openalex-snapshot
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
inferredcites →https://doi.org/10.1016/j.drudis.2014.11.011openalex-snapshot
Targeting xenobiotic receptors PXR and CAR in human diseases
inferredcites →https://doi.org/10.1016/j.ejphar.2006.02.028openalex-snapshot
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
inferredcites →https://doi.org/10.1016/j.ejphar.2009.09.002openalex-snapshot
PPARδ ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR−/− mice
inferredcites →https://doi.org/10.1016/j.ejphar.2014.10.055openalex-snapshot
Curcumin regulates peroxisome proliferator-activated receptor-γ coactivator-1α expression by AMPK pathway in hepatic stellate cells in vitro
inferredcites →https://doi.org/10.1016/j.fct.2012.10.030openalex-snapshot
Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils
inferredcites →https://doi.org/10.1016/j.fct.2013.08.036openalex-snapshot
Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.fct.2013.11.015openalex-snapshot
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2011.11.012openalex-snapshot
Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling
inferredcites →https://doi.org/10.1016/j.ijpharm.2015.05.024openalex-snapshot
Effects of formulation design on niacin therapeutics: mechanism of action, metabolism, and drug delivery
inferredcites →https://doi.org/10.1016/j.jcmgh.2014.11.005openalex-snapshot
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1016/j.jhep.2006.02.011openalex-snapshot
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
inferredcites →https://doi.org/10.1016/j.jhep.2010.09.020openalex-snapshot
Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
inferredcites →https://doi.org/10.1016/j.jhep.2013.12.012openalex-snapshot
Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation
inferredcites →https://doi.org/10.1016/j.jhep.2014.06.009openalex-snapshot
ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis
inferredcites →https://doi.org/10.1016/j.jhep.2015.01.019openalex-snapshot
Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
inferredcites →https://doi.org/10.1016/j.jnutbio.2013.09.014openalex-snapshot
Chronic supplementation of proanthocyanidins reduces postprandial lipemia and liver miR-33a and miR-122 levels in a dose-dependent manner in healthy rats
inferredcites →https://doi.org/10.1016/j.jnutbio.2014.10.008openalex-snapshot
Endogenous and exogenous mediators of quercetin bioavailability
inferredcites →https://doi.org/10.1016/j.lfs.2013.12.211openalex-snapshot
Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase
inferredcites →https://doi.org/10.1016/j.mce.2014.04.012openalex-snapshot
Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells
inferredcites →https://doi.org/10.1016/j.metabol.2015.05.002openalex-snapshot
Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.molcel.2008.03.003openalex-snapshot
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
inferredcites →https://doi.org/10.1016/j.nut.2013.11.016openalex-snapshot
Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
inferredcites →https://doi.org/10.1016/j.nutres.2014.09.005openalex-snapshot
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.pharmthera.2014.11.012openalex-snapshot
Cardioprotective potential of annexin-A1 mimetics in myocardial infarction
inferredcites →https://doi.org/10.1016/j.phrs.2012.05.003openalex-snapshot
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats
inferredcites →https://doi.org/10.1016/j.phrs.2014.10.004openalex-snapshot
The emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes
inferredcites →https://doi.org/10.1016/j.plipres.2012.11.002openalex-snapshot
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
inferredcites →https://doi.org/10.1016/j.plipres.2014.01.004openalex-snapshot
Ceramide: A simple sphingolipid with unique biophysical properties
inferredcites →https://doi.org/10.1016/j.taap.2011.11.006openalex-snapshot
A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor
inferredcites →https://doi.org/10.1016/j.taap.2014.08.001openalex-snapshot
Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver
inferredcites →https://doi.org/10.1016/j.yjmcc.2015.04.003openalex-snapshot
Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
inferredcites →https://doi.org/10.1016/s0016-5085(03)00896-5openalex-snapshot
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
inferredcites →https://doi.org/10.1016/s0016-5085(14)63350-3openalex-snapshot
694 Hepatic CXCR3 Promotes Non-Alcoholic Steatohepatitis Through Inflammation, Lipid Accumulation and Autophagy Deficiency
inferredcites →https://doi.org/10.1016/s0092-8674(03)00269-1openalex-snapshot
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
inferredcites →https://doi.org/10.1016/s0140-6736(14)61933-4openalex-snapshot
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
inferredcites →https://doi.org/10.1016/s0168-8278(13)61319-7openalex-snapshot
1319 SIMTUZUMAB, AN ANTIFIBROTIC MONOCLONAL ANTIBODY AGAINST LYSYL OXIDASE-LIKE 2 (LOXL2) ENZYME, APPEARS SAFE AND WELL TOLERATED IN PATIENTS WITH LIVER DISEASE OF DIVERSE ETIOLOGY
inferredcites →https://doi.org/10.1017/s0007114511002753openalex-snapshot
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
inferredcites →https://doi.org/10.1017/s0007114512000347openalex-snapshot
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice
inferredcites →https://doi.org/10.1021/jm025529gopenalex-snapshot
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity
inferredcites →https://doi.org/10.1021/mp800131dopenalex-snapshot
Activation of the Nuclear Receptor PXR Decreases Plasma LDL-Cholesterol Levels and Induces Hepatic Steatosis in LDL Receptor Knockout Mice
inferredcites →https://doi.org/10.1038/aps.2014.149openalex-snapshot
2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice
inferredcites →https://doi.org/10.1038/cddis.2014.162openalex-snapshot
Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD
inferredcites →https://doi.org/10.1038/icb.2015.15openalex-snapshot
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
inferredcites →https://doi.org/10.1038/ijo.2013.155openalex-snapshot
The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men
inferredcites →https://doi.org/10.1038/labinvest.2009.129openalex-snapshot
The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury
inferredcites →https://doi.org/10.1038/labinvest.2012.145openalex-snapshot
Carbon tetrachloride-induced hepatic injury through formation of oxidized diacylglycerol and activation of the PKC/NF-κB pathway
inferredcites →https://doi.org/10.1038/nature05894openalex-snapshot
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
inferredcites →https://doi.org/10.1038/nature09584openalex-snapshot
mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
inferredcites →https://doi.org/10.1038/nature10809openalex-snapshot
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
inferredcites →https://doi.org/10.1038/nm.2208openalex-snapshot
Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
inferredcites →https://doi.org/10.1038/nm.2277openalex-snapshot
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
inferredcites →https://doi.org/10.1038/nm.2279openalex-snapshot
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
inferredcites →https://doi.org/10.1039/c2ob27114aopenalex-snapshot
Discovery of indolyl acrylamide derivatives as human diacylglycerol acyltransferase-2 selective inhibitors
inferredcites →https://doi.org/10.1042/bj20041598openalex-snapshot
Pregnenolone-16α-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms
inferredcites →https://doi.org/10.1042/bj20141455openalex-snapshot
Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action
inferredcites →https://doi.org/10.1042/bj3220567openalex-snapshot
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells
inferredcites →https://doi.org/10.1053/j.gastro.2006.04.012openalex-snapshot
Pregnane X Receptor Activators Inhibit Human Hepatic Stellate Cell Transdifferentiation In Vitro
inferredcites →https://doi.org/10.1053/j.gastro.2007.11.037openalex-snapshot
Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis
inferredcites →https://doi.org/10.1053/j.gastro.2013.10.059openalex-snapshot
Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21
inferredcites →https://doi.org/10.1053/j.gastro.2014.07.044openalex-snapshot
Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
inferredcites →https://doi.org/10.1053/j.gastro.2014.11.039openalex-snapshot
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
inferredcites →https://doi.org/10.1073/pnas.0511167103openalex-snapshot
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
inferredcites →https://doi.org/10.1073/pnas.0701600104openalex-snapshot
βKlotho is required for metabolic activity of fibroblast growth factor 21
inferredcites →https://doi.org/10.1073/pnas.0907342107openalex-snapshot
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
inferredcites →https://doi.org/10.1073/pnas.1006962107openalex-snapshot
Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
inferredcites →https://doi.org/10.1073/pnas.1102281108openalex-snapshot
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
inferredcites →https://doi.org/10.1073/pnas.1103451108openalex-snapshot
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
inferredcites →https://doi.org/10.1073/pnas.1201840109openalex-snapshot
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
inferredcites →https://doi.org/10.1073/pnas.1303377110openalex-snapshot
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
inferredcites →https://doi.org/10.1073/pnas.93.13.6737openalex-snapshot
Expression of galectin-3 modulates T-cell growth and apoptosis.
inferredcites →https://doi.org/10.1074/jbc.274.45.32048openalex-snapshot
Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1
inferredcites →https://doi.org/10.1074/jbc.c113.502310openalex-snapshot
MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasive in Vitro
inferredcites →https://doi.org/10.1074/jbc.m112.386854openalex-snapshot
Identification of Akt-independent Regulation of Hepatic Lipogenesis by Mammalian Target of Rapamycin (mTOR) Complex 2
inferredcites →https://doi.org/10.1074/jbc.m112.417014openalex-snapshot
Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
inferredcites →https://doi.org/10.1074/jbc.m112.437392openalex-snapshot
Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies
inferredcites →https://doi.org/10.1074/jbc.m112.437525openalex-snapshot
Peroxisome Proliferator-activated Receptor α Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor α-mediated Activation of C3 Gene in Mammalian Hepatic-derived Cells
inferredcites →https://doi.org/10.1074/jbc.m114.565960openalex-snapshot
Fibroblast Growth Factor 21 Is Regulated by the IRE1α-XBP1 Branch of the Unfolded Protein Response and Counteracts Endoplasmic Reticulum Stress-induced Hepatic Steatosis
inferredcites →https://doi.org/10.1074/jbc.m209673200openalex-snapshot
Stimulation of Proliferation of Rat Hepatic Stellate Cells by Galectin-1 and Galectin-3 through Different Intracellular Signaling Pathways
inferredcites →https://doi.org/10.1074/jbc.m312697200openalex-snapshot
Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity
inferredcites →https://doi.org/10.1074/jbc.m510713200openalex-snapshot
Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1α
inferredcites →https://doi.org/10.1074/jbc.m704213200openalex-snapshot
Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance
inferredcites →https://doi.org/10.1080/15548627.2015.1009787openalex-snapshot
Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization
inferredcites →https://doi.org/10.1093/carcin/bgt085openalex-snapshot
hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors
inferredcites →https://doi.org/10.1093/cvr/cvt203openalex-snapshot
Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation
inferredcites →https://doi.org/10.1093/glycob/cwu111openalex-snapshot
Galectin-3: an emerging all-out player in metabolic disorders and their complications
inferredcites →https://doi.org/10.1093/jac/dku071openalex-snapshot
Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD)
inferredcites →https://doi.org/10.1093/nar/29.17.3595openalex-snapshot
Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein
inferredcites →https://doi.org/10.1093/nar/gkt1011openalex-snapshot
Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells
inferredcites →https://doi.org/10.1096/fj.02-1157fjeopenalex-snapshot
Inhibition of 5‐lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis
inferredcites →https://doi.org/10.1096/fj.12-213728openalex-snapshot
Attenuation of plasma annexin A1 in human obesity
inferredcites →https://doi.org/10.1096/fj.13-235614openalex-snapshot
Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis
inferredcites →https://doi.org/10.1097/fpc.0b013e328333a1ddopenalex-snapshot
The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1101/gad.1138104openalex-snapshot
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
inferredcites →https://doi.org/10.1111/bph.13109openalex-snapshot
Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice
inferredcites →https://doi.org/10.1111/liv.12331openalex-snapshot
Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/liv.12537openalex-snapshot
Both bone marrow‐derived and non‐bone marrow‐derived cells contribute to AIM 2 and NLRP 3 inflammasome activation in a MyD88‐dependent manner in dietary steatohepatitis
inferredcites →https://doi.org/10.1111/liv.12570openalex-snapshot
The pan‐caspase inhibitor Emricasan ( IDN ‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis
inferredcites →https://doi.org/10.1124/dmd.110.035006openalex-snapshot
Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1124/dmd.114.062307openalex-snapshot
Pregnane X Receptor Modulates the Inflammatory Response in Primary Cultures of Hepatocytes
inferredcites →https://doi.org/10.1124/jpet.105.084905openalex-snapshot
A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis
inferredcites →https://doi.org/10.1124/jpet.108.144600openalex-snapshot
Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
inferredcites →https://doi.org/10.1124/jpet.114.214650openalex-snapshot
Semisynthetic Bile Acid FXR and TGR5 Agonists: Physicochemical Properties, Pharmacokinetics, and Metabolism in the Rat
inferredcites →https://doi.org/10.1124/mol.112.084269openalex-snapshot
Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis–Related Fibrosis in a Dietary Rat Model
inferredcites →https://doi.org/10.1124/mol.114.095141openalex-snapshot
An Overview of Hedgehog Signaling in Fibrosis
inferredcites →https://doi.org/10.1124/mol.114.097287openalex-snapshot
SLC13A5 Is a Novel Transcriptional Target of the Pregnane X Receptor and Sensitizes Drug-Induced Steatosis in Human Liver
inferredcites →https://doi.org/10.1126/science.93.2409.203openalex-snapshot
THE AMERICAN DIABETES ASSOCIATION
inferredcites →https://doi.org/10.1126/scitranslmed.3004690openalex-snapshot
Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex
inferredcites →https://doi.org/10.1128/mcb.00049-13openalex-snapshot
Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
inferredcites →https://doi.org/10.1128/mcb.00677-14openalex-snapshot
Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance
inferredcites →https://doi.org/10.1128/mcb.00992-07openalex-snapshot
Identification of a Domain within Peroxisome Proliferator-Activated Receptor γ Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in Adipocytes
inferredcites →https://doi.org/10.1136/gutjnl-2013-306290openalex-snapshot
Galectin-3 regulates hepatic progenitor cell expansion during liver injury
inferredcites →https://doi.org/10.1146/annurev.med.60.101107.134820openalex-snapshot
Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1152/ajpendo.00157.2006openalex-snapshot
PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1
inferredcites →https://doi.org/10.1152/ajpgi.00073.2014openalex-snapshot
Activation ofN-methyl- d -aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathway
inferredcites →https://doi.org/10.1152/ajpgi.00181.2013openalex-snapshot
Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1152/ajpgi.00222.2012openalex-snapshot
Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury
inferredcites →https://doi.org/10.1152/ajpgi.00365.2011openalex-snapshot
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
inferredcites →https://doi.org/10.1152/ajplung.00370.2014openalex-snapshot
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent
inferredcites →https://doi.org/10.1155/2013/938401openalex-snapshot
Interactions between Human Liver Fatty Acid Binding Protein and Peroxisome Proliferator Activated Receptor Selective Drugs
inferredcites →https://doi.org/10.1155/2014/169216openalex-snapshot
Serum Oxidative Stress Markers and Lipidomic Profile to Detect NASH Patients Responsive to an Antioxidant Treatment: A Pilot Study
inferredcites →https://doi.org/10.1155/2014/751859openalex-snapshot
Coordinated Actions of FXR and LXR in Metabolism: From Pathogenesis to Pharmacological Targets for Type 2 Diabetes
inferredcites →https://doi.org/10.1155/2015/272313openalex-snapshot
Rapamycin Improves Palmitate‐Induced ER Stress/NFκB Pathways Associated with Stimulating Autophagy in Adipocytes
inferredcites →https://doi.org/10.1155/2015/597134openalex-snapshot
The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism
inferredcites →https://doi.org/10.1158/0008-5472.can-05-0104openalex-snapshot
Implication of Galectin-3 in Wnt Signaling
inferredcites →https://doi.org/10.1158/0008-5472.can-05-1197openalex-snapshot
Galectin-3 Inhibits Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis by Activating Akt in Human Bladder Carcinoma Cells
inferredcites →https://doi.org/10.1161/atvbaha.109.186791openalex-snapshot
Accelerated Lipid-Induced Atherogenesis in Galectin-3-Deficient Mice
inferredcites →https://doi.org/10.1161/atvbaha.112.300345openalex-snapshot
Myeloid Deletion of Nuclear Factor Erythroid 2−Related Factor 2 Increases Atherosclerosis and Liver Injury
inferredcites →https://doi.org/10.1161/atvbaha.114.304584openalex-snapshot
Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes
showing the first 200 of 286 · page through all 286

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4859731openalex-extracted
Daphnetin Alleviates Nash by Modulating Lipid Metabolism, Bile Acids and Gut Microbiota in Mcd Diet Mice
inferred← citeshttps://doi.org/10.1001/jamainternmed.2016.9607openalex-snapshot
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1002/advs.201801585openalex-snapshot
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
inferred← citeshttps://doi.org/10.1002/biof.1987openalex-snapshot
Nomilin and its analogue obacunone alleviate NASH and hepatic fibrosis in mice via enhancing antioxidant and anti‐inflammation capacity
inferred← citeshttps://doi.org/10.1002/cbdv.202200401openalex-snapshot
Salidroside in the Treatment of NAFLD/NASH
inferred← citeshttps://doi.org/10.1002/ctm2.1529openalex-snapshot
DEAD‐Box Helicase 17 exacerbates non‐alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages
inferred← citeshttps://doi.org/10.1002/fsn3.1200openalex-snapshot
Fermented black radish (Raphanus sativus L. var. niger) attenuates methionine and choline deficient diet‐induced nonalcoholic fatty liver disease in mice
inferred← citeshttps://doi.org/10.1002/fsn3.2459openalex-snapshot
Protective effect of Salidroside on hypoxia‐related liver oxidative stress and inflammation via Nrf2 and JAK2/STAT3 signaling pathways
inferred← citeshttps://doi.org/10.1002/hep.28709openalex-snapshot
Bile acids and nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/hep.28960openalex-snapshot
Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: New evidence, new challenges
inferred← citeshttps://doi.org/10.1002/hep.28971openalex-snapshot
The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis
inferred← citeshttps://doi.org/10.1002/hep.29820openalex-snapshot
Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice
inferred← citeshttps://doi.org/10.1002/hep.29845openalex-snapshot
Time to step‐up the fight against NAFLD
inferred← citeshttps://doi.org/10.1002/hep.30950openalex-snapshot
Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3
inferred← citeshttps://doi.org/10.1002/hep.31599openalex-snapshot
NAFLD: Reporting Histologic Findings in Clinical Practice
inferred← citeshttps://doi.org/10.1002/hep.32078openalex-snapshot
Guanine Nucleotide‐Binding Protein G(i) Subunit Alpha 2 Exacerbates NASH Progression by Regulating Peroxiredoxin 1–Related Inflammation and Lipophagy
inferred← citeshttps://doi.org/10.1002/hep.32153openalex-snapshot
The RNA binding protein human antigen R is a gatekeeper of liver homeostasis
inferred← citeshttps://doi.org/10.1002/hep.32165openalex-snapshot
The transcription factor zinc fingers and homeoboxes 2 alleviates NASH by transcriptional activation of phosphatase and tensin homolog
inferred← citeshttps://doi.org/10.1002/hep4.1072openalex-snapshot
The selective peroxisome proliferator–activated receptor‐delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice
inferred← citeshttps://doi.org/10.1002/hep4.1195openalex-snapshot
Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes
inferred← citeshttps://doi.org/10.1002/hep4.1270openalex-snapshot
Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice
inferred← citeshttps://doi.org/10.1002/hep4.1368openalex-snapshot
Tropifexor‐Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in Rodents
inferred← citeshttps://doi.org/10.1002/hep4.1396openalex-snapshot
Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
inferred← citeshttps://doi.org/10.1002/jcb.28468openalex-snapshot
Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/jcp.29795openalex-snapshot
Long noncoding RNA CCAT1 inhibits miR‐613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription
inferred← citeshttps://doi.org/10.1002/med.21515openalex-snapshot
Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/mnfr.201600632openalex-snapshot
Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency
inferred← citeshttps://doi.org/10.1002/oby.22627openalex-snapshot
Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1002/smll.202410638openalex-snapshot
Cross‐Referencing Multifluid Metabolic Profiles on Hollow Dodecahedral Nanocages for Enhanced Disease Status Identification
inferred← citeshttps://doi.org/10.1007/978-3-030-11748-1_14openalex-snapshot
Animal Models of Type 2 Diabetes, Obesity and Nonalcoholic Steatohepatitis – Clinical Translatability and Applicability in Preclinical Drug Development
inferred← citeshttps://doi.org/10.1007/978-3-319-57732-6_30openalex-snapshot
Metabolic Disorders and Cancer: Hepatocyte Store-Operated Ca2+ Channels in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-981-13-1426-1_22openalex-snapshot
Circular RNAs in Metabolic Diseases
inferred← citeshttps://doi.org/10.1007/s00018-026-06132-1openalex-snapshot
The degradation revolution: harnessing targeted protein degradation for the treatment of human diseases
inferred← citeshttps://doi.org/10.1007/s00204-023-03490-8openalex-snapshot
In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity
inferred← citeshttps://doi.org/10.1007/s00726-017-2429-yopenalex-snapshot
Relevance of autophagy to fatty liver diseases and potential therapeutic applications
inferred← citeshttps://doi.org/10.1007/s10620-018-5080-xopenalex-snapshot
Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?
inferred← citeshttps://doi.org/10.1007/s10620-018-5395-7openalex-snapshot
Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1007/s10620-019-05657-9openalex-snapshot
Vitamin E Ameliorates Lipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease via Nrf2/CES1 Signaling Pathway
inferred← citeshttps://doi.org/10.1007/s10620-020-06748-8openalex-snapshot
A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s10753-019-00967-6openalex-snapshot
Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1007/s12072-020-10096-0openalex-snapshot
Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism
inferred← citeshttps://doi.org/10.1007/s13105-022-00876-7openalex-snapshot
Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis
inferred← citeshttps://doi.org/10.1007/s40199-026-00644-8openalex-snapshot
Hepatic stellate cells in alcoholic liver cirrhosis: mechanisms of fibrogenesis, plasticity, and fibrosis reversal
inferred← citeshttps://doi.org/10.1007/s40495-017-0085-2openalex-snapshot
Role of FXR in Liver Inflammation During Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1016/b978-0-12-822186-0.00024-9openalex-snapshot
Nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-849886-6.00021-5openalex-snapshot
Master role of glucose-6-phosphate in cell signaling and consequences of its deregulation in the liver and kidneys
inferred← citeshttps://doi.org/10.1016/b978-0-7020-6697-9.00005-4openalex-snapshot
Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/b978-0-7020-8228-3.00005-3openalex-snapshot
Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.actbio.2025.07.010openalex-snapshot
A ROS/ultrasound dual-responsive nanocarrier enhances drug penetration for ameliorating metabolic dysfunction-associated steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.ajpath.2025.06.012openalex-snapshot
Peroxisome Proliferator–Activated Receptor Agonist IVA337 Alleviates Inflammation and Fibrosis in MASH by Restoring Lipid Homeostasis
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.07.006openalex-snapshot
Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy
inferred← citeshttps://doi.org/10.1016/j.apsb.2024.10.010openalex-snapshot
Akkermansia muciniphila-derived acetate activates the hepatic AMPK/SIRT1/PGC-1α axis to alleviate ferroptosis in metabolic-associated fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.04.003openalex-snapshot
Self-degradable “gemini-like” ionizable lipid-mediated delivery of siRNA for subcellular-specific gene therapy of hepatic diseases
inferred← citeshttps://doi.org/10.1016/j.artere.2021.09.001openalex-snapshot
Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway
inferred← citeshttps://doi.org/10.1016/j.arteri.2020.12.007openalex-snapshot
Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway
inferred← citeshttps://doi.org/10.1016/j.atherosclerosis.2017.04.018openalex-snapshot
Linking lysosomal acid lipase insufficiency to the development of cryptogenic cirrhosis
inferred← citeshttps://doi.org/10.1016/j.bbadis.2019.03.006openalex-snapshot
Chemokine (C-C motif) ligand 2 gene ablation protects low-density lipoprotein and paraoxonase-1 double deficient mice from liver injury, oxidative stress and inflammation
inferred← citeshttps://doi.org/10.1016/j.bbalip.2016.07.008openalex-snapshot
Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.bbrc.2017.12.148openalex-snapshot
Autophagy dysregulation caused by ApoM deficiency plays an important role in liver lipid metabolic disorder
inferred← citeshttps://doi.org/10.1016/j.bbrc.2018.07.094openalex-snapshot
Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116073openalex-snapshot
Apical papilla stem cell-derived exosomes regulate lipid metabolism and alleviate inflammation in the MCD-induced mouse NASH model
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2019.01.008openalex-snapshot
Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.119823openalex-snapshot
Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2023.122230openalex-snapshot
Inhibition of free heme-catalyzed Fenton-like reaction prevents non-alcoholic fatty liver disease by hepatocyte-targeted hydrogen delivery
inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.110008openalex-snapshot
Euphorbia factor L3 ameliorates hepatic steatosis by activating LKB1-AMPK signaling pathway-regulated lipid metabolism
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116908openalex-snapshot
A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway
inferred← citeshttps://doi.org/10.1016/j.biopha.2026.119656openalex-snapshot
Synbiotics and antioxidants synergistically attenuate disease progression in metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.carbpol.2024.122139openalex-snapshot
RG-I pectin-like polysaccharide from Rosa chinensis inhibits inflammation and fibrosis associated to HMGB1/TLR4/NF-κB signaling pathway to improve non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.carpta.2024.100442openalex-snapshot
Chitosan based nanocarriers as a promising tool in treatment and management of inflammatory diseases
inferred← citeshttps://doi.org/10.1016/j.cbi.2017.10.010openalex-snapshot
Baicalin protects AML-12 cells from lipotoxicity via the suppression of ER stress and TXNIP/NLRP3 inflammasome activation
inferred← citeshttps://doi.org/10.1016/j.cell.2025.11.031openalex-snapshot
Hepatic adaptation to chronic metabolic stress primes tumorigenesis
inferred← citeshttps://doi.org/10.1016/j.cellsig.2023.110741openalex-snapshot
HMGA2 knockdown alleviates the progression of nonalcoholic fatty liver disease (NAFLD) by downregulating SNAI2 expression
inferred← citeshttps://doi.org/10.1016/j.celrep.2026.116942openalex-snapshot
Hepatocyte PLAGL2 deficiency alleviates MASH through MYD88-licensed inactivation of inflammasome
inferred← citeshttps://doi.org/10.1016/j.cgh.2016.08.002openalex-snapshot
New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis–Related Kidney Disease
inferred← citeshttps://doi.org/10.1016/j.chemosphere.2021.129727openalex-snapshot
Thiamethoxam induces nonalcoholic fatty liver disease in mice via methionine metabolism disturb via nicotinamide N-methyltransferase overexpression
inferred← citeshttps://doi.org/10.1016/j.chemphyslip.2016.09.003openalex-snapshot
Rapid tin-mediated access to a lysophosphatidylethanolamine (LPE) library: Application to positional LC/MS analysis for hepatic LPEs in non-alcoholic steatohepatitis model mice
inferred← citeshttps://doi.org/10.1016/j.clinre.2017.10.005openalex-snapshot
A new pathway to eSCAPe lipotoxicity
inferred← citeshttps://doi.org/10.1016/j.cmet.2016.10.012openalex-snapshot
Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
inferred← citeshttps://doi.org/10.1016/j.cmet.2020.03.007openalex-snapshot
TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation
inferred← citeshttps://doi.org/10.1016/j.cmet.2021.09.008openalex-snapshot
DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing
inferred← citeshttps://doi.org/10.1016/j.cmet.2024.05.008openalex-snapshot
Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH
inferred← citeshttps://doi.org/10.1016/j.cmet.2025.01.016openalex-snapshot
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism
inferred← citeshttps://doi.org/10.1016/j.dld.2020.09.007openalex-snapshot
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.dld.2023.06.015openalex-snapshot
Fecal microbiota transplantation improves hepatic fibro-inflammation via regulating oxidative stress in experimental NASH
inferred← citeshttps://doi.org/10.1016/j.drudis.2017.06.007openalex-snapshot
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2021.112256openalex-snapshot
Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.114089openalex-snapshot
Discovery of a tricyclic farnesoid X receptor agonist HEC96719, a clinical candidate for treatment of non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115307openalex-snapshot
Machine learning- and structure-based discovery of a novel chemotype as FXR agonists for potential treatment of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.ejphar.2019.172715openalex-snapshot
Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy
inferred← citeshttps://doi.org/10.1016/j.ejphar.2023.175811openalex-snapshot
Design and pharmaceutical evaluation of bifunctional fusion protein of FGF21 and GLP-1 in the treatment of nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.foodres.2025.116426openalex-snapshot
Ginsenoside Rk1 Ameliorates Non-Alcoholic Fatty Liver Disease by Targeting CD36 to Modulate the AMPK Signaling Pathway
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2016.09.009openalex-snapshot
Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2018.04.003openalex-snapshot
Hepatocyte-specific deletion of LASS2 protects against diet-induced hepatic steatosis and insulin resistance
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2018.06.043openalex-snapshot
IRE1α aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2018.08.024openalex-snapshot
Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2020.12.020openalex-snapshot
Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress
inferred← citeshttps://doi.org/10.1016/j.immuni.2020.04.001openalex-snapshot
Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.intimp.2019.105797openalex-snapshot
Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106865openalex-snapshot
Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT/mTOR/SREBP-2 pathway
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.111429openalex-snapshot
Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier
inferred← citeshttps://doi.org/10.1016/j.jceh.2019.09.004openalex-snapshot
NASH-inducing Diets in Göttingen Minipigs
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2019.10.010openalex-snapshot
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2023.02.010openalex-snapshot
Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2024.101449openalex-snapshot
Aquaporin-7 Deficiency Attenuates Liver Fibrosis by Inhibiting the Activation and Proliferation of Hepatic Stellate Cells
inferred← citeshttps://doi.org/10.1016/j.jep.2026.121475openalex-snapshot
Babaodan alleviates MAFLD through hepatic glycerophospholipid metabolism and PPARγ/RXRA/GPAT3 based on spatial metabolomics and proteomics analysis
inferred← citeshttps://doi.org/10.1016/j.jep.2026.122201openalex-snapshot
Babaodan ameliorates metabolic dysfunction-associated steatotic liver disease with co-modulation of FXR, NF-κB, and SLC22A7 in bile acid metabolism
inferred← citeshttps://doi.org/10.1016/j.jff.2017.01.032openalex-snapshot
Supplementation with Lycium chinense fruit extract attenuates methionine choline-deficient diet-induced steatohepatitis in mice
inferred← citeshttps://doi.org/10.1016/j.jhep.2015.11.036openalex-snapshot
TM6SF2 may drive postprandial lipoprotein cholesterol toxicity away from the vessel walls to the liver in NAFLD
inferred← citeshttps://doi.org/10.1016/j.jhep.2016.08.024openalex-snapshot
Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.jhep.2019.09.014openalex-snapshot
Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.04.033openalex-snapshot
Danger signals in liver injury and restoration of homeostasis
inferred← citeshttps://doi.org/10.1016/j.jhep.2023.12.029openalex-snapshot
TRIB3–TRIM8 complex drives NAFLD progression by regulating HNF4α stability
inferred← citeshttps://doi.org/10.1016/j.jhepr.2021.100346openalex-snapshot
New targets for NAFLD
inferred← citeshttps://doi.org/10.1016/j.jnutbio.2020.108363openalex-snapshot
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis
inferred← citeshttps://doi.org/10.1016/j.jpba.2021.113964openalex-snapshot
Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing
inferred← citeshttps://doi.org/10.1016/j.jpeds.2017.10.036openalex-snapshot
Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease–Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production
inferred← citeshttps://doi.org/10.1016/j.jsxm.2020.02.021openalex-snapshot
Unwinding Fibrosis in Peyronie's Disease
inferred← citeshttps://doi.org/10.1016/j.jtos.2022.07.006openalex-snapshot
The role of sphingolipids in meibomian gland dysfunction and ocular surface inflammation
inferred← citeshttps://doi.org/10.1016/j.lddd.2026.100347openalex-snapshot
Computational docking and structure–activity relationship analysis of triazine analogues as selective PDE4B and PDE4D inhibitors
inferred← citeshttps://doi.org/10.1016/j.lfs.2017.11.027openalex-snapshot
Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice
inferred← citeshttps://doi.org/10.1016/j.lfs.2019.116644openalex-snapshot
(5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice
inferred← citeshttps://doi.org/10.1016/j.lfs.2019.116834openalex-snapshot
Strength training reduces lipid accumulation in liver of obese Wistar rats
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.117795openalex-snapshot
CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.livres.2018.09.004openalex-snapshot
Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease
inferred← citeshttps://doi.org/10.1016/j.livres.2021.08.003openalex-snapshot
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.matbio.2017.12.012openalex-snapshot
Matrix metalloproteinases and liver fibrosis (translational aspects)
inferred← citeshttps://doi.org/10.1016/j.mehy.2026.111970openalex-snapshot
Metabolic dysfunction associated steatotic liver disease as a disorder of hepatic bioenergetic timing
inferred← citeshttps://doi.org/10.1016/j.metabol.2020.154320openalex-snapshot
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.metabol.2024.155830openalex-snapshot
Perturbed liver gene zonation in a mouse model of non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.metabol.2026.156733openalex-snapshot
HSF1-UCHL1 transcriptional axis protects against MASLD via regulation of PPARα protein stability
inferred← citeshttps://doi.org/10.1016/j.molmet.2018.07.006openalex-snapshot
Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
inferred← citeshttps://doi.org/10.1016/j.molmet.2023.101789openalex-snapshot
PRDX1 Cys52Ser variant alleviates nonalcoholic steatohepatitis by reducing inflammation in mice
inferred← citeshttps://doi.org/10.1016/j.nano.2022.102538openalex-snapshot
Platelet–neutrophil hybrid membrane-coated gelatin nanoparticles for enhanced targeting ability and intelligent release in the treatment of non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.omtn.2021.11.008openalex-snapshot
Dissecting the single-cell transcriptome underlying chronic liver injury
inferred← citeshttps://doi.org/10.1016/j.omtn.2025.102807openalex-snapshot
Circular RNA encoding relaxin-2 as a potential therapy for liver fibrosis
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2017.07.008openalex-snapshot
Stable isotope-based flux studies in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.phrs.2017.04.021openalex-snapshot
Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling
inferred← citeshttps://doi.org/10.1016/j.phymed.2021.153666openalex-snapshot
Network pharmacology-based identification of significant pathway for protection of Yinhuang granule in a mice model of metabolic-associated fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.phymed.2023.155016openalex-snapshot
Corilagin alleviates liver fibrosis in zebrafish and mice by repressing IDO1-mediated M2 macrophage repolarization
inferred← citeshttps://doi.org/10.1016/j.phytol.2022.06.005openalex-snapshot
The isoxazole based flavonoid derivative 1 ameliorates non-alcoholic fatty liver disease in high-fat diet-induced obese mice by regulating lipid metabolism and inflammatory responses
inferred← citeshttps://doi.org/10.1016/j.plefa.2021.102377openalex-snapshot
PUFA, genotypes and risk for cardiovascular disease
inferred← citeshttps://doi.org/10.1016/j.plipres.2023.101238openalex-snapshot
Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
inferred← citeshttps://doi.org/10.1016/j.redox.2022.102582openalex-snapshot
Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice
inferred← citeshttps://doi.org/10.1016/j.tips.2018.01.003openalex-snapshot
Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
inferred← citeshttps://doi.org/10.1016/j.tiv.2016.11.014openalex-snapshot
Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system
inferred← citeshttps://doi.org/10.1016/j.vascn.2019.106651openalex-snapshot
Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent models
inferred← citeshttps://doi.org/10.1016/s1875-5364(18)30077-3openalex-snapshot
Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes in simvastatin pharmacokinetics
inferred← citeshttps://doi.org/10.1016/s1875-5364(21)60002-xopenalex-snapshot
Pathogenesis of NASH and Promising Natural Products
inferred← citeshttps://doi.org/10.1017/jns.2018.27openalex-snapshot
Hot water extract of turmeric (Curcuma longa) prevents non-alcoholic steatohepatitis in mice by inhibiting hepatic oxidative stress and inflammation
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.9b00631openalex-snapshot
Theranostic Quercetin Nanoparticle for Treatment of Hepatic Fibrosis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01065openalex-snapshot
Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00641openalex-snapshot
Discovery of (E)-3-(3-((2-Cyano-4′-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c02431openalex-snapshot
Design, Synthesis, and Biological Evaluation of Chromone Derivatives as STAT1 Inhibitors for Treatment of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b01621openalex-snapshot
Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.1c01107openalex-snapshot
Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.2c00259openalex-snapshot
Xyloketal B Reverses Nutritional Hepatic Steatosis, Steatohepatitis, and Liver Fibrosis through Activation of the PPARα/PGC1α Signaling Pathway
inferred← citeshttps://doi.org/10.1021/acs.jnatprod.2c00990openalex-snapshot
Dihydrotrichodimerol Purified from the Marine Fungus Acremonium citrinum Prevents NAFLD by Targeting PPARα
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.8b01030openalex-snapshot
Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice
inferred← citeshttps://doi.org/10.1021/acschembio.7b00420openalex-snapshot
Ex Vivo Cell-Based Screening Platform for Modulators of Hepatosteatosis
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.0c00647openalex-snapshot
A New FXR Ligand Chemotype with Agonist/Antagonist Switch
inferred← citeshttps://doi.org/10.1021/jasms.0c00032openalex-snapshot
PINE: An Automation Tool to Extract and Visualize Protein-Centric Functional Networks
inferred← citeshttps://doi.org/10.1038/nm.4290openalex-snapshot
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
inferred← citeshttps://doi.org/10.1038/nm.4334openalex-snapshot
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
inferred← citeshttps://doi.org/10.1038/s41374-018-0112-xopenalex-snapshot
Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis
inferred← citeshttps://doi.org/10.1038/s41374-019-0344-4openalex-snapshot
Maternal diet intervention before pregnancy primes offspring lipid metabolism in liver
inferred← citeshttps://doi.org/10.1038/s41392-021-00507-5openalex-snapshot
Pyroptosis: mechanisms and diseases
inferred← citeshttps://doi.org/10.1038/s41401-019-0310-0openalex-snapshot
WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice
inferred← citeshttps://doi.org/10.1038/s41401-021-00629-0openalex-snapshot
Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease
inferred← citeshttps://doi.org/10.1038/s41401-021-00725-1openalex-snapshot
Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis
inferred← citeshttps://doi.org/10.1038/s41419-018-0752-1openalex-snapshot
MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression
inferred← citeshttps://doi.org/10.1038/s41419-020-2293-7openalex-snapshot
Antagonizing circRNA_002581–miR-122–CPEB1 axis alleviates NASH through restoring PTEN–AMPK–mTOR pathway regulated autophagy
inferred← citeshttps://doi.org/10.1038/s41419-020-2582-1openalex-snapshot
Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling
inferred← citeshttps://doi.org/10.1038/s41419-022-05003-4openalex-snapshot
Proteomic analysis reveals USP7 as a novel regulator of palmitic acid-induced hepatocellular carcinoma cell death
inferred← citeshttps://doi.org/10.1038/s41419-023-05613-6openalex-snapshot
Restoration of lipid homeostasis between TG and PE by the LXRα-ATGL/EPT1 axis ameliorates hepatosteatosis
inferred← citeshttps://doi.org/10.1038/s41420-022-00840-wopenalex-snapshot
Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model
inferred← citeshttps://doi.org/10.1038/s41423-020-00579-3openalex-snapshot
Immunological mechanisms and therapeutic targets of fatty liver diseases
inferred← citeshttps://doi.org/10.1038/s41467-019-09524-zopenalex-snapshot
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα
inferred← citeshttps://doi.org/10.1038/s41467-020-16991-2openalex-snapshot
Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
inferred← citeshttps://doi.org/10.1038/s41467-020-19668-yopenalex-snapshot
AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
inferred← citeshttps://doi.org/10.1038/s41467-022-33493-5openalex-snapshot
Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
inferred← citeshttps://doi.org/10.1038/s41467-024-47553-5openalex-snapshot
Lipopolysaccharide binding protein resists hepatic oxidative stress by regulating lipid droplet homeostasis
inferred← citeshttps://doi.org/10.1038/s41467-024-51571-8openalex-snapshot
RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment
inferred← citeshttps://doi.org/10.1038/s41467-025-55939-2openalex-snapshot
Inhibited peroxidase activity of peroxiredoxin 1 by palmitic acid exacerbates nonalcoholic steatohepatitis in male mice
inferred← citeshttps://doi.org/10.1038/s41467-025-63022-zopenalex-snapshot
Dysregulation of GTPase-activating protein-binding protein1 in the pathogenesis of metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1038/s41467-025-65415-6openalex-snapshot
The E3 ligase tripartite motif 7 drives the progression of non-alcoholic fatty liver disease by targeting DUSP10 degradation in male mice
inferred← citeshttps://doi.org/10.1038/s41575-020-00386-1openalex-snapshot
Human biomimetic liver microphysiology systems in drug development and precision medicine
inferred← citeshttps://doi.org/10.1038/s41598-017-17447-2openalex-snapshot
In vivo redox metabolic imaging of mitochondria assesses disease progression in non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1038/s41598-018-22082-6openalex-snapshot
Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling
inferred← citeshttps://doi.org/10.1038/s41598-018-25098-0openalex-snapshot
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
inferred← citeshttps://doi.org/10.1038/s41598-025-92282-4openalex-snapshot
Mechanisms of rifaximin inhibition of hepatic fibrosis in mice with metabolic dysfunction associated steatohepatitis through the TLR4/NFκB pathway
inferred← citeshttps://doi.org/10.1038/s41598-026-37494-yopenalex-snapshot
The metabolic dysfunction-associated steatohepatitis (MASH) drug resmetirom exhibits broad nuclear receptor activity with minimal functional impact
inferred← citeshttps://doi.org/10.1038/s42255-022-00627-4openalex-snapshot
Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis
inferred← citeshttps://doi.org/10.1039/c6fo01591copenalex-snapshot
Preventive effect of Silibinin in combination with Pu-erh tea extract on non-alcoholic fatty liver disease in ob/ob mice
inferred← citeshttps://doi.org/10.1039/c8ra02849dopenalex-snapshot
Rosmarinic acid attenuates hepatic steatosis by modulating ER stress and autophagy in oleic acid-induced HepG2 cells
inferred← citeshttps://doi.org/10.1039/d0ra09320copenalex-snapshot
Pharmacophore modeling and virtual screening studies for discovery of novel farnesoid X receptor (FXR) agonists
inferred← citeshttps://doi.org/10.1039/d1fo02989dopenalex-snapshot
Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice
inferred← citeshttps://doi.org/10.1039/d2fo03054copenalex-snapshot
Integration of transcriptomics and metabonomics revealed the protective effects of hemp seed oil against methionine–choline-deficient diet-induced non-alcoholic steatohepatitis in mice
inferred← citeshttps://doi.org/10.1039/d4md00477aopenalex-snapshot
Evaluating the therapeutic potential of genetically engineered probiotic Zbiotics (ZB183) for non-alcoholic steatohepatitis (NASH) management via modulation of the cGAS-STING pathway
inferred← citeshttps://doi.org/10.1042/cs20160025openalex-snapshot
Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments
inferred← citeshttps://doi.org/10.1053/j.gastro.2018.06.031openalex-snapshot
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
showing the first 200 of 412 · page through all 412
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.